Skip to content

CDR

Aquestive Therapeutics announces FDA approval for Sympazan

Aquestive Therapeutics announces FDA approval for Sympazan

WARREN, N.J. – Aquestive Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved Sympazan (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.

Time to vote for the next Wahl Man of the Year

Time to vote for the next Wahl Man of the Year

Men’s grooming leader, Wahl, wants consumers to know there’s another beard bandwagon that everyone can jump on. Now through Dec. 1, 2018, by voting in the Wahl Man of the Year Contest you can help determine the best beard in America. Over the last year Wahl traveled to the Top 10 Most Facial Hair

Dr. Reddy’s releases generic version of Strattera

Dr. Reddy’s releases generic version of Strattera

Dr. Reddy’s Laboratories announced the roll out of its atomoxetine capsules. The product is for the treatment of attention-deficit/hyperactivity disorder, is a generic version of Eli Lilly’s Strattera. Dr. Reddy’s atomoxetine capsules are available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100